IP Library Granted Patent US 7,045,151
Granted Patent B2
US 7,045,151 · App. 10/252,698 · Granted May 16, 2006

Method and composition for improving fertility health in female and male animals and humans

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,045,151
App. No.
10/252,698
Granted
May 16, 2006
Kind
B2
Abstract

In a new pharmaceutical combination, the herb, Vitex agnus - castus (chasteberry), enhances hormone balance by increasing progesterone release and, therefore, ovulation frequency. The antioxidants, green tea, vitamin E, and selenium, improve overall reproductive health. L-arginine, an amino acid, stimulates the reproductive organs by improving circulation. Folic acid, vitamins B6 and B12, iron, zinc and magnesium help promote womens' fertility. Sperms are highly susceptible to free radical or oxidative damage from environmental toxicants and natural aging. Vitamins C and E, coenzyme Q10 and selenium are all potent antioxidants that help improve sperm counts and quality. Ferulic acid, an antioxidant found in Dong quai, also improves sperm quality. Zinc and B vitamins (B6, B12 and folate) are critical nutrients in male reproductive systems for hormone metabolism, sperm formation and motility. The amino acid, L-carnitine, promotes formation of healthy sperm.

Claims (23)

1. A pharmaceutical composition having fertility promoting activity in males comprising components present in the proportion in parts by weight of

about 20 to 80% L-carnitine,

about 5 to 30% vitamins C and E,

about 0.1 to 10% coenzyme Q10,

about 0.001 to 1% selenium,

about 0.2 to 20% ferulic acid,

about 0.1 to 2% zinc, and

about 0.001 to 1% B vitamins.

2. A pharmaceutical composition having fertility promoting activity in males comprising components present in the proportion in parts by weight of

about 10 to 80% L-carnitine,

about 5 to 50% vitamins C and E,

about 0.1 to 15% coenzyme Q10,

about 0.001 to 1% selenium,

about 0.2 to 20% ferulic acid,

about0.1 to 15% zinc, and

about 0.001 to 1% B vitamins.

3. The pharmaceutical composition of claim 2 , further comprising components present in the proportion in parts by weight of

about 60% L-carnitine,

about 25% vitamins C and E,

about 6% ferulic acid,

about 5% zinc and B vitamins,

about 5% coenzyme Q10, and

about 0.6% selenium.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2022
From: THE DAILY WELLNESS COMPANY
To: THE DAILY WELLNESS COMPANY LLC
Reel/Frame 060768/0346 →